A detailed history of Ars Investment Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ars Investment Partners, LLC holds 29,856 shares of ABBV stock, worth $5.37 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
29,856
Previous 29,676 0.61%
Holding current value
$5.37 Million
Previous $5.09 Million 15.82%
% of portfolio
0.6%
Previous 0.54%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $29,491 - $35,879
180 Added 0.61%
29,856 $5.9 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $155,099 - $181,121
-1,002 Reduced 3.27%
29,676 $5.09 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $6,192 - $6,973
-45 Reduced 0.15%
30,678 $4.75 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $12,023 - $13,918
-90 Reduced 0.29%
30,723 $4.58 Million
Q2 2023

Jul 11, 2023

BUY
$132.51 - $164.9 $208,305 - $259,222
1,572 Added 5.38%
30,813 $4.15 Million
Q1 2023

Apr 05, 2023

BUY
$144.61 - $166.54 $50,613 - $58,289
350 Added 1.21%
29,241 $4.66 Million
Q4 2022

Jan 25, 2023

SELL
$138.31 - $165.87 $1.4 Million - $1.67 Million
-10,090 Reduced 25.88%
28,891 $0
Q3 2022

Oct 07, 2022

BUY
$134.21 - $153.93 $917,996 - $1.05 Million
6,840 Added 21.28%
38,981 $5.23 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $128,152 - $159,001
-971 Reduced 2.93%
32,141 $5.21 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $113,123 - $143,134
-1,053 Reduced 3.08%
33,112 $4.48 Million
Q3 2021

Nov 05, 2021

SELL
$106.4 - $120.78 $6.48 Million - $7.36 Million
-60,927 Reduced 64.07%
34,165 $3.69 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $129,197 - $143,933
1,228 Added 1.31%
95,092 $10.7 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $35,600 - $39,191
348 Added 0.37%
93,864 $10.2 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $1.04 Million - $1.4 Million
12,876 Added 15.97%
93,516 $10 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $9,707 - $11,393
113 Added 0.14%
80,640 $7.06 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $5.48 Million - $7.33 Million
74,647 Added 1269.51%
80,527 $7.91 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $230,816 - $288,800
3,200 Added 119.4%
5,880 $521,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $188,940 - $227,160
-3,000 Reduced 52.82%
2,680 $203,000
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $52,560 - $67,184
800 Added 16.39%
5,680 $413,000
Q1 2019

May 09, 2019

SELL
$77.14 - $90.79 $1.41 Million - $1.66 Million
-18,319 Reduced 78.96%
4,880 $393,000
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $1.81 Million - $2.23 Million
23,199 New
23,199 $2.14 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $22.7 Million - $25.2 Million
-255,329 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $83,495 - $98,793
930 Added 0.37%
255,329 $23.7 Million
Q1 2018

May 04, 2018

BUY
$92.01 - $123.21 $7.46 Million - $9.99 Million
81,101 Added 46.8%
254,399 $24.1 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $32,868 - $36,043
367 Added 0.21%
173,298 $16.8 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $12.1 Million - $15.4 Million
172,931
172,931 $15.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ars Investment Partners, LLC Portfolio

Follow Ars Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.